BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/19/2014 8:18:00 AM | Browse: 517 | Download: 593
Publication Name World Journal of Gastroenterology
Manuscript ID 6674
Country Japan
Received
2013-10-26 17:23
Peer-Review Started
2013-10-27 13:27
To Make the First Decision
2014-01-09 12:29
Return for Revision
2014-01-11 19:35
Revised
2014-01-29 22:29
Second Decision
2014-04-09 08:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 08:58
Articles in Press
2014-05-23 10:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-08-29 11:48
Publish the Manuscript Online
2014-09-18 19:50
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Methylation-mediated gene silencing as biomarkers of gastric cancer: A review
Manuscript Source Invited Manuscript
All Author List Jun Nakamura, Tomokazu Tanaka, Yoshihiko Kitajima, Hirokazu Noshiro and Kohji Miyazaki
Funding Agency and Grant Number
Corresponding Author Jun Nakamura, MD, PhD, Department of Surgery, Saga University Faculty of Medicine, 5-1-1 Nabeshima, Saga 849-8501, Japan. nakamurj@cc.saga-u.ac.jp
Key Words Gastric cancer; Methylation; Biomarker; Early detection; Drug sensitivity
Core Tip This article summarizes the current understanding and recent evidence regarding DNA methylation markers in gastric cancer (GC) and includes our previous works. Current diagnostic and therapeutic tools of GC have not been successful in decreasing the global burden of this disease; however, it is promising that the early diagnosis and careful selection of patient subsets prior to initiating chemotherapy is a key factor for improving the outcomes of patients with GC. Methylation biomarkers would be useful for different purposes, including early detection, classification, assessment of the tumor prognosis, the development of therapeutic strategies and patient follow-up.
Publish Date 2014-09-18 19:50
Citation Nakamura J, Tanaka T, Kitajima Y, Noshiro H, Miyazaki K. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review. World J Gastroenterol 2014; 20(34): 11991-12006
URL http://www.wjgnet.com/1007-9327/full/v20/i34/11991.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i34.11991
Full Article (PDF) WJG-20-11991.pdf
Full Article (Word) WJG-20-11991.doc
Manuscript File 6674-Review.docx
Answering Reviewers 6674-Answering reviewers.pdf
Copyright License Agreement 6674-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6674-Language certificate.pdf
Peer-review Report 6674-Peer review(s).pdf
Scientific Editor Work List 6674-Scientific editor work list.doc